Page 915 - Robbins Basic Pathology by Vinay Kumar, Abul K. Abbas, Jon C. Aster
P. 915

Postmortem clot  88b–89b                                                                                                        Index 901
Postnatal genetic analysis  268
Potter sequence. See Oligohydramnios sequence                 Prostatitis
Prader-Willi syndrome  243–245, 244f                               clinical features of  664
Preeclampsia/eclampsia                                             prostate disease and  663–664
                                                                   summary for  664b
     clinical features of  704
     diseases of pregnancy and  703–704                       Prosthetic cardiac valve  395–396
     morphology of  704b                                      Protein
     summary for  704b
Pregnancy, diseases of                                             damage to  16
     ectopic pregnancy as  701                                     intracellular accumulation of  23
     gestational trophoblastic disease as  701–703            Protein, signal-transducing
     placental inflammations and infections as  701                ABL and  180
     preeclampsia/eclampsia as  703–704                            introduction to  179–180
Pregnancy, ectopic                                                 RAS protein and  179–180
     diseases of pregnancy and  701                           Protein-coding gene
     morphology of  701b                                           alterations other than mutations
     summary for  701b
Prematurity, infant  249–250                                            epigenetic changes as  217
Primary amyloidosis                                                     genetic abnormalities and  216–218
     immunocyte dyscrasias as  155                                      non-coding RNA alterations as  217–218
     lymphoplasmacytic lymphoma and  438                                sequence and copy number variations as  216–217
Primary biliary cirrhosis (PBC)                                    mutations in  216
     cholestatic liver diseases and  627, 627t                Protein-energy malnutrition (PEM)
     clinical course of  627                                       discussion of  294–295
     morphology of  627b–628b, 627f–628f                           kwashiorkor as  294–295
     pathogenesis of  627b                                         marasmus as  294
Primary hypercoagulability  81f, 87                                morphology of  295b
Primary immune deficiency                                          secondary protein-energy malnutrition and  295
     common variable immunodeficiency as  141                 Proteoglycan  64
     genetic deficiencies of innate immunity as  142–143      Protozoa  313
     hyper-IgM syndrome as  141                               PSA test  211
     introduction to  139–143, 140f                           Pseudogout  789–790
     isolated IgA deficiency as  141                          Pseudomonas aeruginosa  490
     lymphocyte activation defects as  142                    Psoriasis
     severe combined immunodeficiency as  142                      chronic inflammatory dermatosis and  854–855
     summary for  142–143, 143b                                    clinical features of  854–855
     with thrombocytopenia and eczema  142                         morphology of  854b, 855f
     thymic hypoplasia as  141                                     pathogenesis of  854b
     X-linked agammaglobulinemia as  140–141                  Pulmonary angiitis  485
Primary sclerosing cholangitis (PSC)                          Pulmonary anthracosis  475b
     cholestatic liver diseases and  627t, 628–629            Pulmonary disease
     clinical course of  629                                       as drug- and radiation-induced  478
     morphology of  628b, 629f                                     of vascular origin
Primary syphilis  672, 673f                                             diffuse alveolar hemorrhage syndromes as  485
Primary tuberculosis  495–496, 496f                                     pulmonary embolism, hemorrhage, infarction as 
Primitive neuroectodermal tumor (PNET). See Ewing sarcoma
Prinzmetal angina  376                                                    482–483
Prion  309–314                                                          pulmonary hypertension as  484
Prion disease                                                 Pulmonary disease, obstructive vs restrictive  462–463
     Creutzfeldt-Jakob disease as  831                        Pulmonary embolism, hemorrhage, infarction
     nervous system infections and  831–832, 831f                  clinical features of  483
     variant Creutzfeldt-Jakob disease as  831                     diseases of vascular origin and  482–483
Progressive massive fibrosis (PMF)  475, 475f. See also Coal       morphology of  482b, 483f
     worker’s pneumoconiosis (CWP)                                 summary for  483b
Progressive multifocal leukoencephalopathy (PML)              Pulmonary eosinophilia  481
     828–829                                                  Pulmonary hypertension
     morphology of  829b, 829f                                     clinical features of  484
Progressive pulmonary tuberculosis  497b                           morphology of  484b, 485f
Prolactinoma  719–720                                              pathogenesis of  484b
Prostaglandin                                                      of vascular origin  484
     anti-inflammatory drugs and  46–47                       Pulmonary hypertension, secondary  134
     arachidonic acid metabolites and  46–47                  Pulmonary hypertensive heart disease. See Cor Pulmonale
Prostate                                                      Pulmonary infection
     benign prostatic hyperplasia and  664–665                     aspiration pneumonias as  492
     carcinoma of  665–668                                         chronic pneumonias as  492–499
     male genital system and  663–668, 663f                        community-acquired acute pneumonias as  486–490
     prostatitis and  663–664                                      community-acquired atypical pneumonias as  490–491
                                                                   histoplasmosis, coccidioidomycosis, blastomycosis as  499–500
                                                                   hospital-acquired pneumonias as  491–492
                                                                   in human immunodeficiency virus infection  504
                                                                   lung abscess as  492
                                                                   the lungs and  486–504, 487f, 488t
   910   911   912   913   914   915   916   917   918   919   920